1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : SPECIALTY PHARMACEUTICALS
  4. CLEVER LEAVES HOLDINGS INC

Clever Leaves Holdings Inc

XNAS: CLVV

Watchlist

Portfolio

Share


Insider Trading disclosures for Clever Leaves Holdings Inc

The latest disclosure was made by Henry R. Hague in Clever Leaves Holdings Inc where a trade of 170 Common shares done at an average price of $3.3 was reported to US exchanges on March 8, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Henry R. Hague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 3.31 per share. 08 Mar 2024 170 11,951 - 3.3 563 Common shares
Hague R. Henry Chief Financial Officer Sale of securities on an exchange or to another person at price $ 3.95 per share. 27 Feb 2024 411 12,121 - 3.9 1,623 Common shares
Julian Wilches Chief Regulatory Officer Sale of securities on an exchange or to another person at price $ 2.89 per share. 19 Jan 2024 131 7,408 - 2.9 378 Common shares
Fajardo Andres Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 2.88 per share. 19 Jan 2024 1,561 21,795 - 2.9 4,502 Common shares
Andres Fajardo Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 2.03 per share. 20 Dec 2023 177 23,356 - 2.0 360 Common shares
Julian Wilches Chief Regulatory Officer Sale of securities on an exchange or to another person at price $ 2.04 per share. 20 Dec 2023 135 7,539 - 2.0 275 Common shares
Andres Fajardo Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.22 per share. 18 Jul 2023 2,938 705,996 - 0.2 632 Common shares
Julian Wilches Chief Regulatory Officer Sale of securities on an exchange or to another person at price $ 0.22 per share. 18 Jul 2023 813 230,205 - 0.2 175 Common shares
Henry R. Hague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.22 per share. 18 Jul 2023 1,560 375,948 - 0.2 336 Common shares
Gary M. Julien Director Sale of securities on an exchange or to another person at price $ 0.21 per share. 29 Jun 2023 251 122,025 - 0.2 52 Common shares
William Muecke Director Sale of securities on an exchange or to another person at price $ 0.21 per share. 29 Jun 2023 251 110,257 - 0.2 52 Common shares
William Muecke Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2023 40,000 110,508 - 0 Common shares
Elisabeth H. DeMarse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2023 40,000 122,276 - 0 Common shares
Gary M. Julien Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2023 40,000 122,276 - 0 Common shares
George J. Schultze Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2023 40,000 115,276 - 0 Common shares
Andres Fajardo Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2023 183,000 708,934 - 0 Common shares
Julian Wilches Chief Regulatory Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2023 183,000 231,018 - 0 Common shares
Henry R. Hague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2023 183,000 377,508 - 0 Common shares
Henry R. Hague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.37 per share. 03 Mar 2023 5,678 194,508 - 0.4 2,091 Common shares
Henry R. Hague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.42 per share. 24 Feb 2023 9,018 200,186 - 0.4 3,832 Common shares
Henry R. Hague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.44 per share. 22 Feb 2023 9,728 209,204 - 0.4 4,282 Common shares
Andres Fajardo Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.40 per share. 17 Jan 2023 57,669 525,934 - 0.4 23,102 Common shares
Julian Wilches Chief Regulatory Officer Sale of securities on an exchange or to another person at price $ 0.40 per share. 17 Jan 2023 4,557 48,018 - 0.4 1,826 Common shares
Andres Fajardo Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.34 per share. 20 Dec 2022 5,133 583,603 - 0.3 1,745 Common shares
Julian Wilches Chief Regulatory Officer Sale of securities on an exchange or to another person at price $ 0.34 per share. 20 Dec 2022 3,829 52,575 - 0.3 1,302 Common shares
Henry R. Hague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 1.03 per share. 06 Jul 2022 598 218,932 - 1.0 616 Common shares
Julian Wilches Chief Regulatory Officer Sale of securities on an exchange or to another person at price $ 1.03 per share. 06 Jul 2022 288 56,404 - 1.0 297 Common shares
Andres Fajardo Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 1.03 per share. 06 Jul 2022 1,170 588,736 - 1.0 1,205 Common shares
David M. Kastin General Counsel Sale of securities on an exchange or to another person at price $ 1.03 per share. 06 Jul 2022 565 172,151 - 1.0 582 Common shares
William Muecke Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2022 68,807 70,508 - 0 Common shares
George J. Schultze Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2022 68,807 75,276 - 0 Common shares
Gary M. Julien Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2022 68,807 82,276 - 0 Common shares
Elisabeth H. DeMarse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2022 68,807 82,276 - 0 Common shares
William Muecke Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2022 1,701 1,701 - 0 Common shares
Henry R. Hague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 1.00 per share. 03 Mar 2022 4,981 219,530 - 1 4,981 Common shares
David M. Kastin General Counsel Sale of securities on an exchange or to another person at price $ 1.00 per share. 03 Mar 2022 2,364 172,716 - 1 2,364 Common shares
George J. Schultze Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2022 6,469 6,469 - 0 Common shares
Kyle Detwiler Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2022 500,000 2,652,771 - 0 Common shares
David M. Kastin General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2022 115,436 130,080 - 0 Common shares
Andres Fajardo Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2022 520,000 589,906 - 0 Common shares
Julian Wilches Chief Regulatory Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2022 20,147 56,692 - 0 Common shares
Henry R. Hague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2022 144,926 224,511 - 0 Common shares
Henry R. Hague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 19,585 79,585 - 0 Common shares
Henry R. Hague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 19,585 19,585 - - Restricted Share Units
Julian Wilches Chief Regulatory Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 6,528 0 - - Restricted Share Units
Julian Wilches Chief Regulatory Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 6,528 39,861 - 0 Common shares
Andres Fajardo Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 29,378 74,378 - 0 Common shares
Andres Fajardo Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 29,378 29,378 - - Restricted Share Units
Kyle Detwiler Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 29,378 29,378 - - Restricted Share Units
Kyle Detwiler Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 29,378 2,199,161 - 0 Common shares
Etienne H. Deffarges Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 6,469 13,469 - 0 Common shares
Gary M. Julien Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 6,469 13,469 - 0 Common shares
Elisabeth H. DeMarse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 6,469 13,469 - 0 Common shares
Kyle Detwiler Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2021 45,000 2,169,783 - 0 Common shares
Kyle Detwiler Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 45,000 0 - - Restricted Share Units
Andres Fajardo Director, President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 45,000 0 - - Restricted Share Units
Andres Fajardo Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2021 45,000 45,000 - 0 Common shares
Julian Wilches Chief Regulatory Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2021 33,333 33,333 - 0 Common shares
Julian Wilches Chief Regulatory Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 33,333 0 - - Restricted Share Units
Henry R. Hague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2021 60,000 60,000 - 0 Common shares
Henry R. Hague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2021 40,000 40,000 - - Stock Option (right to buy)
Andres Fajardo Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2021 45,000 45,000 - - Restricted Share Units
Andres Fajardo Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2021 45,000 45,000 - - Restricted Share Units
Kyle Detwiler Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2021 45,000 45,000 - - Restricted Share Units
Kyle Detwiler Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2021 45,000 45,000 - - Restricted Share Units
Kyle Detwiler Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2021 200,000 2,124,783 - 0 Common shares
Etienne H. Deffarges Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2021 7,000 7,000 - 0 Common shares
Elisabeth H. DeMarse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2021 7,000 7,000 - 0 Common shares
Gary M. Julien Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2021 7,000 7,000 - 0 Common shares
Kyle Detwiler Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2020 18,703 18,703 - - Stock Option (right to buy)
Amit Pandey Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2020 4,675 4,675 - - Stock Option (right to buy)
Amit Pandey Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2020 39,285 39,285 - - Common shares
Amit Pandey Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2020 4,483 43,768 - - Common shares
Amit Pandey Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2020 1,186 1,186 - - Stock Option (right to buy)
Julian Wilches Chief Regulatory Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2020 691,035 691,035 - - Common shares
Julian Wilches Chief Regulatory Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2020 35,733 35,733 - - Stock Option (right to buy)
Julian Wilches Chief Regulatory Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2020 2,443 2,443 - - Stock Option (right to buy)
Andres Fajardo Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2020 3,204 3,204 - - Stock Option (right to buy)
Andres Fajardo Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2020 20,973 20,973 - - Stock Option (right to buy)
Andres Fajardo Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2020 405,607 405,607 - - Common shares
Kyle Detwiler Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2020 236,243 236,243 - - Common shares
Kyle Detwiler Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2020 1,924,783 1,924,783 - - Common shares
Kyle Detwiler Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2020 2,967 2,967 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters